|
- 2018
Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver MutationDOI: 10.14740/wjon1084w Keywords: Lymphocyte to monocyte ratio, Modified Glasgow prognostic score, Neutrophil to lymphocyte ratio, Non-small cell lung cancer, Adenocarcinoma, Wild-type epidermal growth factor receptor, Chemotherapy, Overall survival Abstract: Neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and modified Glasgow prognostic score (mGPS) are useful prognostic markers based on host-related systemic inflammatory response. They have been shown as independent prognostic biomarkers in various cancers, including non-small cell lung cancer. However, there has been little evidence for a specific population of pulmonary adenocarcinoma without active epidermal growth factor receptor (EGFR) mutation
|